Navigation Links
ProMetic provides business update - Over $35 million worth of business secured in January
Date:2/6/2008

o active in therapeutic drug development with the mission to bring to market effective, innovative, lower cost, less toxic products for the treatment of hematology and cancer. Its drug discovery platform is focused on replacing complex, expensive proteins with synthetic "drug-like" protein mimetics. Headquartered in Montreal (Canada), ProMetic has R&D facilities in the U.K., the U.S. and Canada, manufacturing facilities in the U.K. and business development activities in the US, Europe, Asia and in the Middle-East.

Forward Looking Statements

This press release contains forward-looking statements about ProMetic's objectives, strategies and businesses that involve risks and uncertainties. These statements are "forward-looking" because they are based on our current expectations about the markets we operate in and on various estimates and assumptions. Actual events or results may differ materially from those anticipated in these forward-looking statements if known or unknown risks affect our business, or if our estimates or assumptions turn out to be inaccurate. Such risks and assumptions include, but are not limited to, ProMetic's ability to develop, manufacture, and successfully commercialize value-added pharmaceutical products, the availability of funds and resources to pursue R&D projects, the successful and timely completion of clinical studies, the ability of ProMetic to take advantage of business opportunities in the pharmaceutical industry, uncertainties related to the regulatory process and general changes in economic conditions. You will find a more detailed assessment of the risks that could cause actual events or results to materially differ from our current expectations on page 21 of ProMetic's Annual Information Form for the year ended December 31, 2006, under the heading "Risk Factors". As a result, we cannot guarantee that any forward-looking statement will materialize. We assume no obligation to update any forward-looking statement even if
'/>"/>

SOURCE PROMETIC LIFE SCIENCES INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. ProMetic announces scale-up of prion removal resin in plasma product for biopharmaceutical use
2. ProMetic and MacoPharma announce successful completion of P-Capt(R) prion reduction filter clinical studies
3. Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
4. Cephalon Provides Update on Regulatory Status of the FENTORA Supplemental New Drug Application
5. Amarin Provides Business Update and Announces Implementation of Reverse Stock Split
6. YM BioSciences provides update on AeroLEF(TM) clinical development program
7. ViroPharma Provides 2008 Outlook
8. Evotec Provides Update on Planned NASDAQ Listing in the Context of its Announced Acquisition of Renovis
9. Cinpathogen Provides Clinical Diagnostic Consulting Services to Shanghai Area Hospitals
10. Strativa Pharmaceuticals, the Proprietary Products Division of Par Pharmaceutical, Provides an Update on Development Status of Pafuramidine and Other in-Licensed Products
11. Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)...   BioClinica ® , Inc., a specialty ... David Peters , an accomplished senior finance and ... Chief Financial Officer (CFO) and will be joining BioClinica ... than 25 years of financial and accounting experience with ... deep knowledge in all areas of finance, accounting and ...
(Date:6/2/2015)... ST. LOUIS , June 2, 2015 /PRNewswire/ ... leading Life Science and Technology company, announced today ... XCell Science to launch genetically engineered human ... to advance the research of neurological diseases. These ... portfolio, provide unique and versatile tools for the ...
(Date:6/2/2015)... HONG KONG , June 2, 2015 /PRNewswire/ -- China Cord ... "us" and "our"), China,s leading provider ... and stem cell storage services, today announced that the Special ... has appointed Houlihan Lokey ( China ... Steen & Hamilton LLP as its United ...
(Date:6/2/2015)... 2015 GOJO, inventors of PURELL ® ... stewardship at the White House Forum.  GOJO was among ... and stakeholders at the White House Forum to announce ... emergence of antibiotic-resistant bacteria, detect resistant strains, preserve the ... of resistant infections. "A primary prevention approach ...
Breaking Biology Technology:BioClinica Names David Peters New Chief Financial Officer 2Sigma-Aldrich to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells 2Sigma-Aldrich to Launch XCell Science Genetically Engineered iPSC-Derived Neural Disease Cells 3China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 2GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 4
... Md. , Feb. 5 Novavax, Inc. (Nasdaq: NVAX ... , President and Chief Executive Officer of Novavax will be presenting at ... 2010 at 10:00 am local time. Hosted by the ... will take place February 8-9 at the Waldorf = ...
... high-grade plastic draws oil out of contaminated water but leaves the ... be squeezed back out for use. , Case Western Reserve ... will effectively clean up spills of all kinds of oils and ... EPA estimates that 10 to 25 million gallons of oil are ...
... , DENVER , Feb. 4 ... employment communities for the hospitality and healthcare industries, are two ... job seekers. , (Photo: http://www.newscom.com/cgi-bin/prnh/20100204/FL49504LOGO-a ) , (Photo: ... Hcareers for the User,s Choice Award three times since WEDDLE,s ...
Cached Biology Technology:NOVAVAX to Present at the 12th Annual BIO CEO & Investor Conference 2New material absorbs, conserves oil 2Industry Web Sites Continue to Win Online Award 2Industry Web Sites Continue to Win Online Award 3
(Date:5/11/2015)... May 11, 2015 Curemark LLC, a privately ... of a new Phase III double blind, randomized, placebo-controlled ... formulation, CM-AT, on all children ages 3-8 with Autism. ... Phase III double blinded clinical trial for CM-AT in ... of the digestive enzyme chymotrypsin. This new trial will ...
(Date:5/8/2015)... , May 8, 2015 Synaptics Inc. (NASDAQ: ... today announced that members of the executive management team will ... 43rd Annual Technology, Media and Telecom Conference Date: May ... in Boston, MA Cowen ... 2015 Time: 2:45pm ET Location: The New York Palace Hotel, ...
(Date:5/6/2015)... , May 6, 2015 LifeBEAM, a ... established helmet producer, announced today that they will expand ... the world,s first bio-sensing cycling helmet and the first ... in two new colors in order to give cyclists ... product. In addition, LifeBEAM and Lazer announced their plan ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2Synaptics to Present at Upcoming Investor Conferences 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 2LifeBEAM and Lazer Announce Expanded Partnership in Bio-Sensing Sports Gear 3
... hybrid laboratory antibodies derived from chimpanzees and humans may ... the serious complications that can occur following smallpox vaccination--and ... The study, led by researchers with the National Institute ... National Institutes of Health (NIH), appears online this week ...
... the McKusick-Nathans Institute of Genetic Medicine at Johns Hopkins ... analyzing what many have termed "junk" DNA and identified ... found that these control regions from different species don't ... study will be published online at Science Express March ...
... state-of-the-art anti-aging technologies may extend human lifespans at an ... and economic challenges, says biologist Shripad Tuljapurkar of Stanford ... would have major implications for the global community in ... Professor of Population Studies, will give a talk Feb. ...
Cached Biology News:Mice studies illustrate potential of chimp/human antibodies to protect against smallpox 2Mice studies illustrate potential of chimp/human antibodies to protect against smallpox 3Junk DNA may not be so junky after all 2Junk DNA may not be so junky after all 3World faces challenge as life expectancies lengthen, scientist says 2World faces challenge as life expectancies lengthen, scientist says 3World faces challenge as life expectancies lengthen, scientist says 4
...
Mouse polyclonal antibody raised against a partial recombinant LASS3. NCBI Entrez Gene ID = 204219...
... The ReadyPrep 2-D starter kit is intended ... and ReadyStrip IPG strips. The kit includes a ... and transfer to second-dimension gels six 17 cm, ... IPG strips (ReadyStrip IPG strips and precast SDS-PAGE ...
... is a fully integrated system for fluorescent ... that deliver excellent quality microarray images. The ... microarray scanner that is based on patented ... rejection and spatial resolution. The DNAscope V ...
Biology Products: